(株)アールテック・ウエノの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証JQS | 医薬品 | 4573/E15678 | R-TECH UENO, LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/06/05 | 日証協 | 589,500株 | -11.88% | 40,700株 | +1750% | 553,436株 | -12.2% | 4,600株 | -96.05% |
2015/05/29 | 日証協 | 669,000株 | 0% | 2,200株 | 0% | 630,349株 | 0% | 116,500株 | 0% |
2015/05/15 | 日証協 | 798,000株 | +0.67% | 17,100株 | +3.01% | 1,008,748株 | -1.36% | 5,700株 | +42.5% |
2015/05/08 | 日証協 | 792,700株 | +0.51% | 16,600株 | -82.23% | 1,022,648株 | -0.62% | 4,000株 | -93.48% |
2015/05/01 | 日証協 | 788,700株 | -2.92% | 93,400株 | -41.33% | 1,029,040株 | +2.02% | 61,308株 | -25.52% |
2015/04/24 | 日証協 | 812,400株 | -4.12% | 159,200株 | -21.73% | 1,008,632株 | +60.96% | 82,316株 | -83.88% |
2015/04/17 | 日証協 | 847,300株 | +10.17% | 203,400株 | -49.73% | 626,624株 | +2.54% | 510,500株 | +65.26% |
2015/04/10 | 日証協 | 769,100株 | +91.27% | 404,600株 | +187.56% | 611,123株 | +89.48% | 308,901株 | +98.78% |
2015/04/03 | 日証協 | 402,100株 | +39.38% | 140,700株 | +35.55% | 322,523株 | +27.52% | 155,402株 | +107.46% |
2015/03/20 | 日証協 | 191,100株 | +71.24% | 106,800株 | +217.86% | 220,815株 | +2.42% | 77,400株 | +79.54% |
2015/03/13 | 日証協 | 111,600株 | +19.49% | 33,600株 | +147.06% | 215,606株 | +5.48% | 43,109株 | -39.2% |
2015/03/06 | 日証協 | 93,400株 | -11.3% | 13,600株 | -61.25% | 204,406株 | +18.56% | 70,900株 | +1588.1% |
2015/02/27 | 日証協 | 105,300株 | +63.26% | 35,100株 | -20.59% | 172,406株 | +18.57% | 4,200株 | -89.37% |
2015/02/20 | 日証協 | 64,500株 | +0.94% | 44,200株 | +2355.56% | 145,406株 | -3.52% | 39,500株 | +1362.96% |
2015/02/13 | 日証協 | 63,900株 | +4.24% | 1,800株 | +5.88% | 150,706株 | +0.8% | 2,700株 | +50% |
2015/02/06 | 日証協 | 61,300株 | -25.15% | 1,700株 | +70% | 149,506株 | -6.85% | 1,800株 | +12.5% |
2015/01/30 | 日証協 | 81,900株 | -9.7% | 1,000株 | -58.33% | 160,506株 | -0.68% | 1,600株 | -56.76% |
2015/01/23 | 日証協 | 90,700株 | -20.09% | 2,400株 | -31.43% | 161,606株 | -11.79% | 3,700株 | +236.36% |
2015/01/16 | 日証協 | 113,500株 | -23.88% | 3,500株 | +1650% | 183,212株 | +0.94% | 1,100株 | -89.22% |
※株式分割は考慮していませんのでご注意ください。
Page Top